Skip to main content

Some squeeze-loving retail investors are being cautious about all those shorts on Longeveron

The biopharma stock shot up more than 865% in 3 days before massive short interest dragged it down almost 50% on Tuesday, but will the Apes pounce?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.